Thursday, November 17, 2005
Print Current Session:
|
|
Thursday
SESSION V:
A NEW CRITICAL LOOK AT CAROTID STENTING (CAS) AND EMBOLIC BRAIN PROTECTION DEVICES (7-MINUTE TALKS)
Moderators:Frank J. Veith, M.D.
|
|
SESSION V SCHEDULE | |
11:12 AM - 11:19 AM | Carotid Echomorphology Correlates With Embolic Risk During CAS: Should Protection Devices Be Used Selectively? |
Presenters(s): Peter H. Lin, M.D. | |
View Abstract | |
11:20 AM - 11:27 AM | Debate: In CAS, Embolic Injury Is Not The Only Risk To The Brain |
Presenters(s): Sumaira Macdonald, MBChB (Comm), MRCP, FRCR, PhD | |
View Abstract | |
11:28 AM - 11:35 AM | Debate: In CAS, Embolic Injury To The Brain Is The Main Problem |
Presenters(s): Klaus D. Mathias, M.D. | |
11:36 AM - 11:43 AM | Hemodynamic Changes During CAS Cause Half The Complications: How Can They Be Prevented? |
Presenters(s): Marc R.H. van Sambeek, M.D., Ph.D. | |
View Abstract | |
11:44 AM - 11:51 AM | Debate: Why The 2-Year SAPPHIRE Trial Results Are So Good For CAS Enthusiasts |
Presenters(s): Kenneth Ouriel, M.D., F.A.C.S., F.A.C.C. | |
View Abstract | |
11:52 AM - 11:59 AM | Debate: Limitations To The Value Of The SAPPHIRE Trial |
Presenters(s): Peter R.F. Bell, M.D., F.R.C.S., D.S.C., K.B.E. | |
View Abstract | |
12:00 PM - 12:07 PM | Lessons Learned To Date From CREST: Why We Need The Randomized Phase Of CREST |
Presenters(s): Robert W. Hobson II, M.D. | |
12:08 PM - 1:08 PM | Lunch Break |
END OF SESSION V |